Publication
Number of items: 17.
18 July 2025
  • Urinary Extracellular Vesicle Signatures as Biomarkers in Prostate Cancer Patients. (2025) Sigrun Lange, Darryl Ethan Bernstein, Nikolay Dimov, Srinivasu Puttaswamy, Ian Johnston, Igor Kraev, Sarah R. Needham, Nikhil Vasdev and Jameel Inal
  • 23 December 2024
  • Animal Models of Human Disease 2.0. (2024) Sigrun Lange and Jameel M. Inal
  • 31 October 2023
  • Animal Models of Human Disease. (2023) Sigrun Lange and Jameel Inal
  • 3 March 2023
  • The Impact of Semicarbazide Sensitive Amine Oxidase Activity on Rat Aortic Vascular Smooth Muscle Cells. (2023) Vesna Manasieva, Shori Thakur, Lisa A. Lione, Anwar R. Baydoun and John Skamarauskas
  • 4 August 2022
  • A Pilot Study on Peptidylarginine Deiminases and Protein Deimination in Animal Cancers across Vertebrate Species. (2022) Jameel M. Inal, Mariya Hristova and Sigrun Lange
  • 16 August 2021
  • Worsening of the Toxic Effects of (±) Cis -4,4′-DMAR Following Its Co-Administration with (±) Trans -4,4′-DMAR: Neuro-Behavioural, Physiological, Immunohistochemical and Metabolic Studies in Mice. (2021) Micaela Tirri, Paolo Frisoni, Sabrine Bilel, Raffaella Arfè, Claudio Trapella, Anna Fantinati, Giorgia Corli, Beatrice Marchetti, Fabio De-Giorgio, Cristian Camuto, Monica Mazzarino, Rosa Maria Gaudio, Giovanni Serpelloni, Fabrizio Schifano, Francesco Botrè and Matteo Marti
  • 12 May 2021
  • Fibrinolysis in platelet thrombi. (2021) Rahim Kanji, Ying X. Gue, Vassilios Memtsas and Diana Gorog
  • 19 March 2021
  • Co-Incubation with PPARβ/δ Agonists and Antagonists Modeled Using Computational Chemistry: Effect on LPS Induced Inflammatory Markers in Pulmonary Artery. (2021) Noelia Perez Diaz, Lisa Lione, Victoria Hutter and Louise Susan Mackenzie description
  • 2 February 2021
  • Role, laboratory assessment and clinical relevance of fibrin, factor XIII and endogenous fibrinolysis in arterial and venous thrombosis. (2021) Vassilios Memtsas, Deepa RJ Arachchillage and Diana Gorog
  • 30 November 2020
  • Synthesis and in silico modelling of the potential dual mechanistic activity of small cationic peptides potentiating the antibiotic novobiocin against susceptible and multi-drug resistant Escherichia coli. (2020) Ilaria Passarini, Pedro Ernesto de Resende, Sarah Soares, Tadeh Tahmasi, Paul Stapleton, John Malkinson, Mire Zloh and Sharon Rossiter description
  • 22 February 2020
  • Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines. (2020) Pinar Uysal-Onganer, Amy MacLatchy, Rayan Mahmoud, Igor Kraev, Paul R Thompson, Jameel Inal and Sigrun Lange
  • 28 December 2018
  • Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme. (2018) Uchini S Kosgodage, Pinar Uysal-Onganer, Amy MacLatchy, Igor Kraev, Nicholas Chatterton, Anthony P. Nicholas, Jameel Inal and Sigrun Lange
  • 1 September 2017
  • Importance of endogenous fibrinolysis in platelet thrombus formation. (2017) Ying X. Gue and Diana A. Gorog
  • 5 June 2017
  • Peptidylarginine Deiminases-Roles in Cancer and Neurodegeneration and Possible Avenues for Therapeutic Intervention via Modulation of Exosome and Microvesicle (EMV) Release? (2017) Sigrun Lange, Mark Gallagher, Sharad Kholia, Uchini S Kosgodage, Mariya Hristova, John Hardy and Jameel M Inal
  • 9 May 2017
  • Chloramidine/Bisindolylmaleimide-I-Mediated Inhibition of Exosome and Microvesicle Release and Enhanced Efficacy of Cancer Chemotherapy. (2017) Uchini S Kosgodage, Rita P Trindade, Paul R Thompson, Jameel M Inal and Sigrun Lange
  • 1 June 2016
  • Identification of excipient-protein interaction hotspots using computational approaches. (2016) Teresa S Barata, Cheng Zhang, Paul A. Darby, Steve Brocchini and Mire Zloh
  • 1 February 2004
  • Molecular similarity of MDR inhibitors. (2004) Mire Zloh and S. Gibbons